Universal absence of merlin, but not other ERM family members, in Schwannomas

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1649-1654

  Stemmer Rachamimov, Anat O ^a   Xu, Lin ^a   Gonzalez Agosti, Charo ^a   Burwick, Jennifer A ^a   Pinney, Denise ^a   Beauchamp, Roberta ^a   Jacoby, Lee B ^a   Gusella, James F ^a   Ramesh, Vijaya ^a   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MERLIN; MOESIN; RADIXIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CHROMOSOME 22Q; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; HUMAN TISSUE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN FAMILY;

BLOOD PROTEINS; BLOTTING, WESTERN; CRANIAL NERVE NEOPLASMS; CYTOSKELETAL PROTEINS; GENES, NEUROFIBROMATOSIS 2; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; NEURILEMMOMA; NEUROFIBROMIN 2; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PHOSPHOPROTEINS; PROTEINS; VESTIBULAR NERVE;

EID: 15144359418     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sainz J, Huynh DP, Figueroa K, Baserm ME, Mautner VF, Pulst SM: Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994, 3:885-891
2. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER: Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994, 3:347-350
3. Lekanne Deprez RH, Bianchi AB, Grown NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwartoff EC: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994, 54:1022-1029
4. Jacoby LB, MacCollin M, Louis DN, Mohoney T, Rubio M-P, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella JF: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994, 3:413-419
5. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJM: Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes & Cancer 1994, 11:7-14
6. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994, 3:147-151
7. Sainz J, Figueroa K, Baser ME, Mautner VF, Pulst SM: High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet 1995, 4:137-139
8. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF: Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes & Cancer 1996, 17:45-55
9. Dianzani I, Camaschella C, Ponzone A, Cotton RGH: Dilemmas and progress in mutation detection. Trends Genet 1993, 9:403-405
10. Wellenreuther R, Draus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Diemling A: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995, 1246:827-832
11. Pulst S-M, Rouleau GA, Marineau C, Fain P, Sieb JP: Familial meningioma is not allelic to neurofibromatosis 2. Neurology 1993, 43:2096-2098
12. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haasse VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993, 72:791-800
13. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993, 363:515-521
14. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 1994, 125:1371-1384
15. Gonzalez-Agosti C, Xu L, Pinney D, Beauchamp R, Hobbs W, Gusella J, Ramesh V: The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 1996, 13:1239-1247
16. Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L, Burwick JA, Beauchamp R, Pinney D, Louis DN, Ramesh V: Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system. J Neuropathol Exp Neurol 1997, 56:735-742
17. Winkler B, Gonzalez-Agosti C, Magendantz M, Solomon F: Analysis of a cortical cytoskeletal structure: a role for ezrin-radixin-moesin (ERM proteins) in the marginal band of chicken erythrocytes. J Cell Sci 1994, 107:2523-2534
18. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
19. Amieva MR, Futhmayr H: Subcellular localization of moesin in dynamic filopodia, retraction fibers and other structures involved in substrate exploration, attachment and cell-cell contacts. Exp Cell Res 1995, 219:180-196
20. Hitotsumatsu T, Iwaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fudui M, Tateishi J: Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 1997, 93:225-232
21. Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst S-M: Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neural 1997, 56:382-390
22. Bianchi AB, Tetsuo H, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 1994, 6:185-192
23. Bianchi AB, Mitsunaga S-I, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJP, Testa JR: High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 1995, 92:10854-10858
24. Sekido Y, Pass H, Bader S, Mew D, Christmas M, Gazdar A, Minna J: Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 1995, 55:1227-1231
25. De Vitis LR, Tedde A, Vitelli F, Ammannati U, Montali E, Papi L: Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Human Genet 1996, 97:632-637
26. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 1994, 6:180-184
27. Andreoli C, Martin M, Le Borgne R, Reggio H, Mangeat P: Ezrin has properties to self-associate at the plasma membrane. J Cell Sci 1994, 107:2509-2521
28. Gary R, Bretscher A: Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell 1995, 6:1061-1075
29. Hirano M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S: Regulation mechanism ot ERM (ezrin/radixin/ moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996, 135:37-51
30. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994, 126:391-401
31. Tsukita S, Shigenobu Y, Tsukita S: ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. Curr Opin Cell Biol 1997, 9:70-75
32. Hunter T: Oncoprotein networks. Cell 1997, 88:333-346
33. Böhling T, Turunen O, Jääskeluäinen J, Carpen O, Sainio M, Wahlström T, Vaheri A, Haltia M: Ezrin expression in stromal cells of capillary hemangioblastoma. Am J Pathol 1996, 367-373